accountNPPA can allow a price increase even if the mark-up percentage is fixed. At least two drugmakers, US-based Eli Lilly and Danish company Novo Nordisk have objected to the price regulator's move, the same two persons quoted above said. While Eli Lilly has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to NPPA rejects increased price of imported medicies; Eli Lilly moves court
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account